John R. Kachura

Mount Sinai Hospital
ON, CA 
Mount Sinai Hospital
ON, CA 

Overview

John Kachura practices practicing medicine in Canada.

His clinical expertise encompasses Renal Cell Carcinoma (RCC), Liver Cancer, Uterine Fibroids, Gastrostomy, and Cardiac Ablation.

He is actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Mount Sinai Hospital
ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, Randomized, Double Blind, Dummy-Controlled Study of ThermoDox® (Lyso-Thermosensitive Liposomal Doxorubicin-LTLD) in Hepatocellular Carcinoma (HCC) Using Standardized Radiofrequency Ablation (RFA) Treatment Time ≥ 45 Minutes for Solitary Lesions ≥ 3 cm to ≤ 7 cm
A Phase III, Randomized, Double Blind, Dummy-Controlled Study of ThermoDox® (Lyso-Thermosensitive Liposomal Doxorubicin-LTLD) in Hepatocellular Carcinoma (HCC) Using Standardized Radiofrequency Ablation (RFA) Treatment Time ≥ 45 Minutes for Solitary Lesions ≥ 3 cm to ≤ 7 cm
Enrollment Status: Completed
Publish Date: August 20, 2024
Intervention Type: Drug
Study Phase: Phase 3
Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial
Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial
Enrollment Status: Completed
Publish Date: February 25, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

41 Total Publications

Non-Malignant Imaging Changes Mimicking Local Tumour Progression of Renal Cell Carcinoma Following Percutaneous Ablation.
Non-Malignant Imaging Changes Mimicking Local Tumour Progression of Renal Cell Carcinoma Following Percutaneous Ablation.
Journal: Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes
Published: January 31, 2026

Frequently Asked Questions about John R. Kachura

Is John R. Kachura a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. John R. Kachura is classified as an Experienced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does John R. Kachura participate in research or clinical trials?

Yes. John R. Kachura has published 41 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of John R. Kachura's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kachura's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile